TR200002750T2 - Paroksetin terkipler. - Google Patents

Paroksetin terkipler.

Info

Publication number
TR200002750T2
TR200002750T2 TR2000/02750T TR200002750T TR200002750T2 TR 200002750 T2 TR200002750 T2 TR 200002750T2 TR 2000/02750 T TR2000/02750 T TR 2000/02750T TR 200002750 T TR200002750 T TR 200002750T TR 200002750 T2 TR200002750 T2 TR 200002750T2
Authority
TR
Turkey
Prior art keywords
paroxetine
paroxetine compositions
compositions
tabletting
carrier
Prior art date
Application number
TR2000/02750T
Other languages
English (en)
Turkish (tr)
Inventor
Simon Craig Andrew
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR200002750T2 publication Critical patent/TR200002750T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2000/02750T 1998-03-24 1999-03-24 Paroksetin terkipler. TR200002750T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Publications (1)

Publication Number Publication Date
TR200002750T2 true TR200002750T2 (tr) 2000-12-21

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02750T TR200002750T2 (tr) 1998-03-24 1999-03-24 Paroksetin terkipler.

Country Status (20)

Country Link
EP (1) EP1063993A1 (xx)
JP (1) JP2002507569A (xx)
CN (1) CN1125639C (xx)
AP (1) AP2000001914A0 (xx)
AU (1) AU754765B2 (xx)
BG (1) BG104865A (xx)
BR (1) BR9908991A (xx)
CA (1) CA2324612A1 (xx)
EA (1) EA003393B1 (xx)
GB (1) GB9806312D0 (xx)
HU (1) HUP0101326A3 (xx)
ID (1) ID26485A (xx)
IL (1) IL138478A0 (xx)
NO (1) NO313404B1 (xx)
NZ (1) NZ506893A (xx)
PL (1) PL343095A1 (xx)
SK (1) SK14102000A3 (xx)
TR (1) TR200002750T2 (xx)
WO (1) WO1999048499A1 (xx)
ZA (1) ZA200005697B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
IL138478A0 (en) 2001-10-31
ID26485A (id) 2001-01-11
EA003393B1 (ru) 2003-04-24
CA2324612A1 (en) 1999-09-30
EA200000977A1 (ru) 2001-02-26
AU3045199A (en) 1999-10-18
HUP0101326A3 (en) 2002-06-28
BR9908991A (pt) 2000-12-12
WO1999048499A1 (en) 1999-09-30
NO20004740D0 (no) 2000-09-22
PL343095A1 (en) 2001-07-30
AP2000001914A0 (en) 2000-09-30
AU754765B2 (en) 2002-11-21
NO20004740L (no) 2000-10-03
EP1063993A1 (en) 2001-01-03
NO313404B1 (no) 2002-09-30
NZ506893A (en) 2003-06-30
CN1294512A (zh) 2001-05-09
JP2002507569A (ja) 2002-03-12
HUP0101326A2 (hu) 2002-05-29
BG104865A (en) 2001-05-31
SK14102000A3 (sk) 2001-03-12
CN1125639C (zh) 2003-10-29
GB9806312D0 (en) 1998-05-20
ZA200005697B (en) 2001-10-02

Similar Documents

Publication Publication Date Title
TR200102342T2 (tr) Paramilon içeren dondurularak kurutulmuş madde, bunun üretimi ve kullanımı.
TR200101643T2 (tr) Mikronize eplerenon bileşimleri.
DE60005994D1 (de) Verflüssigbare pulverzusammensetzungen
DK1157037T3 (da) GCSF-konjugater
TR200100299T2 (tr) Tedavi edici biaril türevleri.
DE69930242D1 (de) Puderzusammensetzungen
DE3575932D1 (de) Komprimierbare staerke als bindemittel fuer tabletten oder kapseln.
BR0011671B1 (pt) pacote de barreira.
ATE249486T1 (de) Wässrige reaktive spachtelmassen (i)
ID26313A (id) Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif
ID22476A (id) Komposisi film polimer untuk kapsul
TR199902082T2 (xx) Pirazin bile�ikleri.
BR9810495A (pt) Composição farmacêutica
TR200200982T2 (tr) Farmasötik bileşim terkipleri.
HRP20020330B1 (xx)
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
TR200103396T2 (tr) Anti-fas antikoru içeren farmasötik terkipler.
TR200002750T2 (tr) Paroksetin terkipler.
TR200103119T2 (tr) Göz kurumasının tedavisi için madde.
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
ZA200007010B (en) Retarding formulations of active substances used for plant protection.
ATE232728T1 (de) Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
ATE268175T1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
NO20014961L (no) Integrin-reseptor-ligander